Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)

Authors :: K. Kang
Zhong Wu
Ben Markman
Gary Richardson
Lisa G. Horvath
Tarek Meniawy
Michael B. Jameson
Jayesh Desai
Hui K Gan
Zhen Qin
Michael Friedlander
Shahneen Sandhu
Amanda R. Townsend
Source :: Annals of Oncology. 28:v130
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Advanced ovarian cancer
medicine.drug_class
business.industry
Hematology
Monoclonal antibody
medicine.disease
03 medical and health sciences
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Immunology
Dose escalation
Cancer research
medicine
Anti-PD-1 Monoclonal Antibody
Ovarian cancer
business
030217 neurology & neurosurgery

Tools